155 related articles for article (PubMed ID: 11428056)
1. [Biological basis for generating resistance to antiretroviral drugs].
Alcamí J; Delgado R; Menéndez-Arias L
Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):3-13. PubMed ID: 11428056
[No Abstract] [Full Text] [Related]
2. Antiretroviral update: recent advances expand options for patients with HIV.
Santhanam H; Goins M
Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568
[No Abstract] [Full Text] [Related]
3. Update of the drug resistance mutations in HIV-1: 2004.
Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD
Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709
[No Abstract] [Full Text] [Related]
4. HIV protease inhibitors.
Winslow DL; Otto MJ
AIDS; 1995; 9 Suppl A():S183-92. PubMed ID: 8819585
[No Abstract] [Full Text] [Related]
5. HIV suppression and risk of drug resistance mutations.
Phillips AN; Loveday C; Johnson MA
AIDS; 1998 Oct; 12(14):1930. PubMed ID: 9792396
[No Abstract] [Full Text] [Related]
6. [Resistance to nucleoside reverse transcriptase inhibitors].
Leal M; Santamaría JM
Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):26-9. PubMed ID: 11428055
[No Abstract] [Full Text] [Related]
7. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.
Recsky MA; Brumme ZL; Chan KJ; Wynhoven B; Yip B; Dong WW; Heath KV; Montaner JS; Levy AR; Hogg RS; Harrigan PR
J Infect Dis; 2004 Jul; 190(2):285-92. PubMed ID: 15216463
[TBL] [Abstract][Full Text] [Related]
8. HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?
Uy J; Brooks JT; Baker R; Hoffman M; Moorman A; Novak R;
Antivir Ther; 2007; 12(6):957-62. PubMed ID: 17926650
[TBL] [Abstract][Full Text] [Related]
9. [Primary resistance to antiretroviral agents].
Soriano V; María Miró J; Guerrero A
Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):22-5. PubMed ID: 11428054
[No Abstract] [Full Text] [Related]
10. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
11. Companies aim at new HIV targets.
Brower V
Nat Biotechnol; 1996 Sep; 14(9):1079. PubMed ID: 9669875
[No Abstract] [Full Text] [Related]
12. [HIV infection. Virus resistance: development and prevention].
Link R; Miller V; Fätkenheuer G; Manegold C; Harrer T
Med Monatsschr Pharm; 1999 Mar; 22(3):86-8. PubMed ID: 10223868
[No Abstract] [Full Text] [Related]
13. [Epidemiology of genotypic resistance of HIV-1 in Valencia. A 4-year study].
Molina JM; Córdoba J; Gil A; Gobernado M
Rev Esp Quimioter; 2007 Sep; 20(3):346-53. PubMed ID: 18080033
[TBL] [Abstract][Full Text] [Related]
14. New anti-HIV agents and targets.
De Clercq E
Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution.
Kantor R; Katzenstein D
AIDS Rev; 2003; 5(1):25-35. PubMed ID: 12875105
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of drug resistance mutations among antiretroviral drug-naive HIV-1-infected patients in China].
Si XF; Huang HL; Wei M; Guan Q; Song YH; Ma PF; Quan Y; Xing H; Shao YM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):308-11. PubMed ID: 15650776
[TBL] [Abstract][Full Text] [Related]
17. Primary drug resistance in antiretroviral-naïve injection drug users.
Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral drug resistance among HIV-1 infected children failing treatment.
Mullen J; Leech S; O'Shea S; Chrystie IL; Du Mont G; Ball C; Sharland M; Cottam F; Zuckerman M; Rice P; Easterbrook P
J Med Virol; 2002 Nov; 68(3):299-304. PubMed ID: 12226814
[TBL] [Abstract][Full Text] [Related]
19. [Detection of primary antiretroviral resistance in Chilean patients recently infected with human immunodeficiency virus (HIV)].
Acevedo W; Gallardo AM; Galaz J; Afani A; Cortés E
Rev Med Chil; 2007 Nov; 135(11):1406-13. PubMed ID: 18259651
[TBL] [Abstract][Full Text] [Related]
20. [German-Austrian guidelines for antiretroviral therapy of HIV infection. (July, 2002, update)].
Brockmeyer NH; ;
Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S7-18. PubMed ID: 12736863
[No Abstract] [Full Text] [Related]
[Next] [New Search]
